companies gilead-sciences-inc 
IP Watchdog
JANUARY 19, 2022
District Court for the Eastern District of New York yesterday unsealed documents in an anticounterfeiting suit filed last year by Gilead Sciences, Inc. against a slew of defendants who Gilead alleges sold, marketed, and distributed counterfeits of its HIV medications.
IP Law 360
JUNE 23, 2023
California federal jurors considering claims that pharmaceutical companies Gilead Sciences Inc. and Teva Pharmaceutical Industries Ltd.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
IP Law 360
OCTOBER 21, 2022
Gilead Sciences Inc. wants a California federal court to toss a proposed class action accusing the pharmaceutical company of paying off would-be generic competitors to its HIV drugs to delay market entry, arguing the allegations are dependent on too much speculation that such competition would've occurred.
IP Law 360
FEBRUARY 10, 2023
A proposed class of consumers slammed Gilead Sciences Inc.'s
IP Law 360
DECEMBER 15, 2021
Managed care company Centene Corp. has hit Gilead Sciences Inc.
The IPKat
SEPTEMBER 15, 2022
Interestingly, several months before this amendment, the Government issued an order allowing a Russian legal entity, “Pharmasyntez”, to use Remdesivir , an antiviral medication used for treatment of Covid-19, without authorization of the patent owner, Gilead Sciences, Inc. company, ABRO Industries, Inc.
The TTABlog
OCTOBER 25, 2022
TTAB Affirms Section 2(a) False Association Refusal of TSA-KIT for "Bottles, sold empty" TTAB Affirms 2(a) False Association Refusal of SEAL TEAM PHYSICAL TRAINING, INC. CAFC Rejects Constitutionality Challenge to Appointment of Administrative Trademark Judges, Affirms TTAB's "SCHIEDMAYER" False Association Decision Precedential No.
Expert insights. Personalized for you.
122 
Let's personalize your content